Sanofi India · NSE: SANOFI · BSE: 500674
Q1 FY27 results · Apr–Jun 2026
Sanofi India reported revenue from operations of ₹437.70 crore (up 7.7% from Q1 FY26) and net profit of ₹83.50 crore (up 20.1% from Q1 FY26) for Q1 FY27 (Apr–Jun 2026), on a standalone basis.
| Item | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 437.70 | 406.30 | +7.7% | 472.30 | −7.3% |
| Other income | 6.20 | 8.70 | −28.7% | 4.40 | +40.9% |
| Total income | 443.90 | 415.00 | +7.0% | 476.70 | −6.9% |
| Profit before tax | 112.30 | 94.10 | +19.3% | 137.90 | −18.6% |
| Net profit for the period | 83.50 | 69.50 | +20.1% | 102.60 | −18.6% |
| EPS, basic (₹) | 36.26 | 30.18 | +20.1% | 44.55 | −18.6% |
| Net margin (%) | 19.1 | 17.1 | 21.7 |
Standalone
- Filed with BSE
- 04 Aug 2026, 20:25 IST
- Board meeting
- 04 Aug 2026
- Period
- 01 Apr 2026 to 30 Jun 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE